Pre-existing Alzheimer's disease is a risk factor for severe/fatal COVID-19 and infection by
SARS-CoV2 virus has been associated with an increased incidence of un-masked …

Background and Purpose Autoimmune encephalitis (AIE) following coronavirus disease
2019 (COVID-19) is an underexplored condition. This study aims to systematically review …

There is still a significant lack of knowledge regarding many aspects of the etiopathology
and consequences of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

The coronavirus disease (COVID-19) pandemic is a leading global health and economic
challenge. What defines the disease's progression is not entirely understood, but there are …

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease after
Alzheimer's disease, globally. Dopaminergic neuron degeneration in substantia nigra pars …

Cardiac manifestations are common in severe COVID-19. This study compared the
histologic, viral, and molecular findings in cardiac tissue in fatal COVID-19 (n= 11) and …

Abstract SARS‐CoV‐2, the etiological agent of COVID-19, is devoid of any metabolic
capacity; therefore, it is critical for the viral pathogen to hijack host cellular metabolic …

It has been more than three years since COVID-19 impacted the lives of millions of people,
many of whom suffer from long-term effects known as long-haulers. Notwithstanding …

Background. Mitochondria have been involved in host defense upon viral infections. Factor
Xa (FXa), a coagulating factor, may also have influence on mitochondrial functionalities. The …

With the decline in the number of new Severe Acute Respiratory Syndrome Coronavirus 2
(SARS‐CoV‐2) infections, the World Health Organization announced the end of the SARS …